Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820443 · ClinicalTrials.gov registry record · Phase 4
Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial
A Phase 4 study, sponsored by MicroPort Orthopedics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 253
- Enrollment target
NCT00820443 is a Phase 4 study that was terminated before completion, run by MicroPort Orthopedics. The registered enrollment target is 253 participants.
The verdict
NCT00820443, a Phase 4 study, was terminated before completion, sponsored by MicroPort Orthopedics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 253 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate non-inferiority of the Ceramic on Metal Total Hip when compared to a TRANSCEND® historical control group of patients with primary total hip replacement.
Interventions
- DEVICE Ceramic on metal prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00820443
The ClinicalTrials.gov registry entry for NCT00820443 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MicroPort Orthopedics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceramic on metal prosthesis is the first listed.
NCT00820443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00820443 about?
NCT00820443 is a clinical study titled "Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial". The purpose of this study is to demonstrate non-inferiority of the Ceramic on Metal Total Hip when compared to a TRANSCEND® historical control group of patients with primary total hip replacement.
What is the current status of trial NCT00820443?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 253 participants. The study started on 2007-06. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00820443?
The interventions under investigation include: Ceramic on metal prosthesis (DEVICE).
Who is sponsoring clinical trial NCT00820443?
This trial is sponsored by MicroPort Orthopedics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.